ALKS 3831

Alkermes sees swift turnaround for rejected schizophrenia med as FDA accepts resubmission
Alkermes sees swift turnaround for rejected schizophrenia med as FDA accepts resubmission
Fierce Biotech
Alkermes
ALKS 5461
ALKS 3831
FDA
drug manufacturing
schizophrenia
Flag link:
Drug rejections rise as Covid-19 bites
Drug rejections rise as Covid-19 bites
EP Vantage
COVID-19
drug approvals
Alkermes
ALKS 3831
pandemic
regulatory inspections
Flag link:
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
Xconomy
Alkermes
FDA
advisory panels
ALKS 3831
schizophrenia
bipolar disorder
Flag link:
FDA Raises Concern Over Opioid Abuse Related to Alkermes' Schizophrenia Drug
FDA Raises Concern Over Opioid Abuse Related to Alkermes' Schizophrenia Drug
BioSpace
Alkermes
FDA
schizophrenia
opioids
ALKS 3831
Flag link:
Virtual FDA AdComm for Alkermes' ALKS 3831 adds new focus on drug-drug interactions
Virtual FDA AdComm for Alkermes' ALKS 3831 adds new focus on drug-drug interactions
Fierce Biotech
Alkermes
schizophrenia
bipolar disorder
FDA
ALKS 3831
Flag link:
A double date with destiny for Alkermes
A double date with destiny for Alkermes
EP Vantage
Alkermes
FDA
clinical trials
ALKS 5461
ALKS 3831
Flag link:
Alkermes says it's advancing 'full steam' with schizophrenia candidate
Alkermes says it's advancing 'full steam' with schizophrenia candidate
Fierce Biotech
Alkermes
schizophrenia
ALKS 3831
Flag link:
Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug
Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug
Xconomy
Alkermes
schizophrenia
side effects
ALKS 3831
clinical trials
Flag link:
Alkermes claims a success in PhIII schizophrenia head-to-head, but where’s the benefit for patients?
Alkermes claims a success in PhIII schizophrenia head-to-head, but where’s the benefit for patients?
Endpoints
Alkermes
schizophrenia
ALKS 3831
clinical trials
Flag link:
Alkermes heads to Phase III with a schizophrenia drug designed to spare the waistline
Alkermes heads to Phase III with a schizophrenia drug designed to spare the waistline
Fierce Biotech
Alkermes
schizophrenia
ALKS 3831
Flag link:
Alkermes sees PhII promise for schizophrenia drug that doesn't pack on pounds
Alkermes sees PhII promise for schizophrenia drug that doesn't pack on pounds
Fierce Biotech
Alkermes
schizophrenia
ALKS 3831
Flag link:
Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Yahoo/Zacks.com
Alkermes
ALKS 3831
schizophrenia
Flag link:
Alkermes' Pipeline Development Impresses, Key Updates Ahead
Alkermes' Pipeline Development Impresses, Key Updates Ahead
Yahoo/Reuters
Alkermes
Invega Sustenna
ALKS 3831
aripiprazole lauroxil
ALKS 5461
Flag link: